Physiotherapy can improve the daily lives of patients who have had knee replacement surgery due to osteoarthritis in the short term, according to a study published on bmj.com today.
Quality of life after treatment for endometrial cancer can be significantly improved by the use of vaginal brachytherapy, where radiotherapy is delivered internally using a vaginal cylinder, the European Cancer Conference (ECCO 14) heard today (Monday September 24).
An international gathering of breast cancer survivors at a Sunshine Coast dragon boat regatta will allow researchers to conduct the world’s first study into the link between air travel and a swollen arm condition suffered by many breast cancer survivors.
In a period of just 13 days, a 56-year-old Gilbert, Ariz., woman has felt the beating of three different hearts – all within her own chest: First, her own, failing heart. Then, in what is considered groundbreaking in the Valley, an artificial heart. And, on day 13, a donor heart.
Researchers at the University of North Carolina at Chapel Hill have patented a synthetic version of the drug heparin, called Recomparin, that is less complex chemically and should be easier to produce than previous forms.
More than 150 million people worldwide are infected with filarial parasites — long, thread-like worms that can live for years inside the human body and cause severe, debilitating diseases such as elephantiasis. Mosquitoes spread the larvae of these parasitic nematodes from human to human, placing at risk more than a billion people who live in places in Africa, Asia and Latin America where filarial parasites thrive.
Based in part on NIGMS-supported research on how gene variation affects a person’s response to medicines, the U.S. Food and Drug Administration has modified the prescribing instructions for warfarin (Coumadin), a widely used blood thinner.
Eli Lilly and Company announced that it has submitted an application with the European Medicines Agency (EMEA) for centralised review of ALIMTA(R) (pemetrexed for injection), in combination with cisplatin, for the first-line treatment of advanced non-small cell lung cancer (NSCLC).
More than 150 million people worldwide are infected with filarial parasites — long, thread-like worms that can live for years inside the human body and cause severe, debilitating diseases such as elephantiasis. Mosquitoes spread the larvae of these parasitic nematodes from human to human, placing at risk more than a billion people who live in places in Africa, Asia and Latin America where filarial parasites thrive.
A new study led by investigators from the University of Pittsburgh School of Medicine demonstrates that the process of necrosis, long thought to be a chaotic, irreversible pathway to cell death, may actually be triggered as part of a regulated response to stress by a powerful protein, SRP-6, that can potentially halt necrosis in its path.